Literature DB >> 23483294

Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review.

Soamarat Vilaiyuk1, Nongnuch Sirachainan, Suthep Wanitkun, Kwanchai Pirojsakul, Jarin Vaewpanich.   

Abstract

Macrophage activation syndrome (MAS) is a fatal complication in rheumatic diseases. It is characterized by prolonged fever, pancytopenia, and hepatosplenomegaly, which are consequences of uncontrolled macrophage activation. MAS in children is most commonly associated with systemic juvenile idiopathic arthritis. Its association with systemic lupus erythematosus (SLE) is relatively rare, so we report a Thai boy who initially presented with MAS and eventually was diagnosed as having SLE. He also had recurrent MAS during the course of therapy. Hyperferritinemia is one of the abnormal laboratory findings in MAS and it has been used as an inflammatory marker. However, its correlation with disease activity remains unclear. Therefore, a review of literature regarding MAS-associated SLE in children and ferritin level in this disease was carried out.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23483294     DOI: 10.1007/s10067-013-2227-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  25 in total

1.  Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome.

Authors:  Olivier Lambotte; Mehdi Khellaf; Hicham Harmouche; Brigitte Bader-Meunier; Véronique Manceron; Cécile Goujard; Zahir Amoura; Bertrand Godeau; Jean-Charles Piette; Jean-François Delfraissy
Journal:  Medicine (Baltimore)       Date:  2006-05       Impact factor: 1.889

2.  Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders.

Authors:  S Sawhney; P Woo; K J Murray
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

3.  Macrophage activation syndrome as an early presentation of Lupus.

Authors:  Liza J McCann; Nathan Hasson; Clarissa A Pilkington
Journal:  J Rheumatol       Date:  2006-02       Impact factor: 4.666

4.  Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab.

Authors:  H Ideguchi; S Ohno; K Takase; H Hattori; Y Kirino; M Takeno; Y Ishigatsubo
Journal:  Rheumatology (Oxford)       Date:  2007-08-27       Impact factor: 7.580

5.  Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases.

Authors:  K Kaito; M Kobayashi; T Katayama; H Otsubo; Y Ogasawara; T Sekita; A Saeki; M Sakamoto; K Nishiwaki; H Masuoka; T Shimada; M Yoshida; T Hosoya
Journal:  Eur J Haematol       Date:  1997-10       Impact factor: 2.997

6.  Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases.

Authors:  S Fukaya; S Yasuda; T Hashimoto; K Oku; H Kataoka; T Horita; T Atsumi; T Koike
Journal:  Rheumatology (Oxford)       Date:  2008-09-09       Impact factor: 7.580

7.  Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection.

Authors:  M Hadchouel; A M Prieur; C Griscelli
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

8.  Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.

Authors:  Edward M Behrens; Timothy Beukelman; Michele Paessler; Randy Q Cron
Journal:  J Rheumatol       Date:  2007-03-01       Impact factor: 4.666

9.  Macrophage activation syndrome resistant to medical therapy in a patient with systemic lupus erythematosus and its remission with splenectomy.

Authors:  Ji Min Kim; Seung Ki Kwok; Ji Hyeon Ju; Kyung Su Park; Gyeong Sin Park; Ho Youn Kim; Sung Hwan Park
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 3.580

10.  A case of acute pericarditis with hemophagocytic syndrome, cytomegalovirus infection and systemic lupus erythematosus.

Authors:  Chang Mo Kwon; Yong Wook Jung; Dae Young Yun; Hyun Do Kim; Hee Soon Cho; Yeong Hoon Hong; Joon Hyuk Choi; Choong Ki Lee
Journal:  Rheumatol Int       Date:  2007-07-12       Impact factor: 3.580

View more
  27 in total

Review 1.  Severe inflammation may be caused by hyperferritinemia of pseudo-pseudo Meigs' syndrome in lupus patients: two cases reports and a literature review.

Authors:  Sang Yeob Lee; Sung Won Lee; Won Tae Chung
Journal:  Clin Rheumatol       Date:  2013-12       Impact factor: 2.980

2.  Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.

Authors:  Li-Xia Zou; Yun Zhu; Li Sun; Hui-Hui Ma; Si-Rui Yang; Hua-Song Zeng; Ji-Hong Xiao; Hai-Guo Yu; Li Guo; Yi-Ping Xu; Mei-Ping Lu
Journal:  World J Pediatr       Date:  2019-10-14       Impact factor: 2.764

3.  Systemic Lupus Erythematosus and Its Association with Hemophagocytic Syndrome as an Initial Manifestation.

Authors:  Jorge Medina Castillo; Ariana Maia Becerra MÁrquez; Isabel Anahí Borjon Cabada
Journal:  Maedica (Bucur)       Date:  2020-12

4.  Gastrointestinal system manifestations in juvenile systemic lupus erythematosus.

Authors:  Hafize Emine Sönmez; Asuman Nur Karhan; Ezgi Deniz Batu; Yelda Bilginer; Ersin Gümüş; Hülya Demir; Aysel Yüce; Seza Özen
Journal:  Clin Rheumatol       Date:  2017-02-16       Impact factor: 2.980

5.  Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with macrophage activation syndrome.

Authors:  Yukang Ding; Yongpeng Ge
Journal:  Ther Adv Chronic Dis       Date:  2022-05-13       Impact factor: 4.970

6.  Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period.

Authors:  Kenan Barut; Gözde Yücel; Ada Bulut Sinoplu; Sezgin Şahin; Amra Adroviç; Özgür Kasapçopur
Journal:  Turk Pediatri Ars       Date:  2015-12-01

7.  Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.

Authors:  Selin Aytaç; Ezgi Deniz Batu; Şule Ünal; Yelda Bilginer; Mualla Çetin; Murat Tuncer; Fatma Gümrük; Seza Özen
Journal:  Rheumatol Int       Date:  2016-08-10       Impact factor: 2.631

8.  Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.

Authors:  Ai-Chun Liu; Yue Yang; Meng-Tao Li; Yuan Jia; Sheng Chen; Shuang Ye; Xiang-Zong Zeng; Zhao Wang; Jin-Xia Zhao; Xiang-Yuan Liu; Jian Zhu; Yan Zhao; Xiao-Feng Zeng; Zhan-Guo Li
Journal:  Clin Rheumatol       Date:  2017-04-13       Impact factor: 3.650

9.  Macrophage Activation Syndrome as Onset of Systemic Lupus Erythematosus: A Case Report and a Review of the Literature.

Authors:  Guido Granata; Dario Didona; Giuseppina Stifano; Aldo Feola; Massimo Granata
Journal:  Case Rep Med       Date:  2015-05-07

10.  Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus: A Systematic Review of the Diagnostic Aspects.

Authors:  Altynay Abdirakhmanova; Vitaliy Sazonov; Zaure Mukusheva; Maykesh Assylbekova; Diyora Abdukhakimova; Dimitri Poddighe
Journal:  Front Med (Lausanne)       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.